Investor directory

Wellington Partners

Wellington Ventures is a venture capital firm specializing in seed stage, start-ups, early stage, late stage, expansion stage, maturity, and growth capital investments. It primarily invests in the technology and life sciences sector. In the technology sector the firm invests in digital media, resource efficiency, and software. In the life sciences sector it invests in medical technology, digital health diagnostics, therapeutics, and industrial biotechnology. Within digital media, it invests in social, local, and/or mobile products and services, shifting media and entertainment consumption models, small businesses leveraging the web, next generation e-commerce model, financial services, financial technology, digital advertising, and gaming. Within the software sector, the firm prefers investment in cloud computing, SaaS, security, data centre software, and mobile business application. It invests in Artificial Intelligence, Food Tech and Ag Tech companies. Within medical technology, it invests in the application of innovative materials, nanotechnology, microelectronics and information technology in medical devices, drug device combinations, and minimally invasive procedures. Within diagnosis, the firm invests in personalize medicine, companion diagnostics, point-of –care diagnosis, monitoring of chronic diseases, early diagnosis of life-threatening diseases such as cancer. It also invests in cleantech, electronics, health science, and medical equipments. The firm seeks to invest in companies based across Europe, German speaking countries, Asia, and the United States. The firm seeks to invest between €7 million ($8.215 million) and €10 million ($11.73 million) in companies with sales value upto $2 million, Enterprise value between $1 million and $ 5 million, and EBITDA upto $0.5 million. It leads financing rounds ranging from €0.5 million ($0.66 million) to €20 million ($26.36 million), in the technology sector, and depending on the maturity of the company, the firm's own commitment can go as high as €15 million ($19.77 million). In case of the life sciences sector, the firm leads financing rounds ranging from €1 million ($1.173 million) to €10 million ($11.73 million) or more, in the technology sector, and depending on the maturity of the company, the firm's own commitment can go as high as €10 million ($11.73 million). Wellington Partners Venture Capital GmbH was founded in 1991 and is based in Munich, Germany with additional offices in Zurich, Switzerland; London, United Kingdom.

Focus

Mid VentureSeries ASeries BEarly VentureTherapeuticsShow more
http://www.wellington-partners.com
https://crunchbase.com/organization/wellington-partners
https://facebook.com/wellingtonpartners
https://linkedin.com/company/wellington-partners
https://signal.nfx.com/firms/wellington-partners
https://twitter.com/wellingtonvc
https://www.capitaliq.com/CIQDotNet/company.aspx?companyId=113360
https://www.privateequityinternational.com/database/#/profile?id=6817
Tuerkenstrasse 5, Munich, Bavaria 80333, DE

Eric Archambeau

General Partner

Frank Böhnke

General Partner

Rolf Christof Dienst

Founder

Stuart Essig

Venture Partner

Johannes Fischer

Principal

Varun Gupta

Principal

Regina Hodits

Managing Partner

Harald Keller

Managing Partner, CFO

Ernst Mannheimer

General Partner

Karl Naegler

Managing Partner

Karl Nägler

Managing Partner

Eberhard Plattfaut

Venture Partner, Europe

Dr. Erich Schlick

Venture Partner

Rainer Strohmenger

Managing Partner

Arturo Urrios

Principal

256 past transactions

Heliatek

Series A in 2007
Heliatek GmbH develops and manufactures organic solar films and photovoltaics cells. Its product includes HeliaSol, an organic photovoltaics (OPV) solution that can be applied to surfaces. The companys’s product is used for building, automotive, and pilot projects applications. The company serves building and construction material companies, automotive manufacturers, and suppliers. Heliatek GmbH has strategic partnerships with AGC Glass Europe, and Reckli China. The company was founded in 2006 and is based in Dresden, Germany.

MTM Laboratories

Series C in 2010
mtm laboratories AG is an ISO 9001 and 13485 certified developer and manufacturer of In-Vitro Diagnostics for the early detection and diagnosis of cervical and other cancers. With headquarters in Heidelberg, Germany, and subsidiaries in the United States, France, Italy and Spain, mtm markets its proprietary CINtec(R) Histology Kit and CINtec(R) Cytology Kit as adjunct tools for the early detection and diagnosis of cervical cancer. These kits are based on mtm's proprietary E6H4(TM) antibody clone which was specifically developed for immunochemistry applications in both formalin-fixed paraffin-embedded tissue sections and alcohol fixed cervical cytology preparations. The target for mtm's cervical cancer early detection technology platforms is the evaluation of the over-expression of the cyclin-dependent kinase inhibitor p16INK4a. This sensitive and selective antibody clone is combined with GMP manufactured kit components to ensure reproducible quality and results.

SENSIMED

Series C in 2012
Sensimed designs, develops, and commercializes integrated micro-systems for medical devices. The company’s product portfolio includes SENSIMED Triggerfish, a product that offers an automated recoding of continuous ocular dimensional change over 24 hours. Sensimed is now focused on expanding the knowledge of how this individual data can best be used in the clinical setting to deliver customized treatment. The 24 hour profiles are being centralized on a registry together with patient and treatment information. The data is being analyzed and modeled on an ongoing basis in an attempt to identifying pathological patterns that can be used to differentiate indication, personalize treatment and assess efficacy following treatment. Sensimed was founded by Matteo Leonardi and Sacha Cerboni in August 2003 and is based in Lausanne, Switzerland.

Wazap

Series B in 2007
Wazap! is a vertical search engine, video game database, and social networking site that aims to distribute gaming news, rankings, cheats, downloads and reviews. It uses a search algorithm, developed internally, to rank indexed pages according to their relevance. Further relevance to the Search engine results page (SERP) is obtained from user interactivity. Users can "Top" or "Flop" any of the results on the SERP and influence its relevance. Wazap!’s "bot" or "crawler" finds gaming related sites across the internet and tags pages according to the pre-defined categories. They also use a user submission tool. Wazap! combines internal proprietary information with their indexed gaming-related information from the web. The results obtained are then accessibly displayed according to the derived quality, publisher submissions, user popularity and preference. Wazap! Was launched by Andreas Ruehrig and is based in Los Angeles, California.

Implanet

Series D in 2010
Implanet S.A., together with its subsidiaries, designs, manufactures, and sells implants for orthopedic surgery in France, the United States, Brazil, and internationally. The company offers spinal, arthroscopy, and knee products. Its products include Jazz, Jazz Passer, Jazz Cap SP, Jazz Lock, Jazz Claw, Jazz Standalone, Jazz Frame, and Jazz Screw systems for posterior fixation. The company also offers knee prostheses, such as Madison for conventional surgical techniques. Implanet S.A. was founded in 2006 and is based in Martillac, France.

AMBOSS GmbH

Private Placement in 2019
AMBOSS GmbH develops and markets medical study platform for medical students and physicians. The platform provides study material and question bank. The company was formerly known as MIAMED GmbH. AMBOSS GmbH was founded in 2012 and is based in Cologne, Germany.

UiPath

Series E in 2020
UiPath designs and develops robotic process automation software. The platform offers foolproof development tools, automation of intricate processes, enhanced control, cloud and on-premise deployment, robust governance, and multiple robots on a single virtual machine. UiPath also provides UiPath Studio that models automation visually, UiPath Orchestrator that manages critical enterprise duties, and UiPath Robot that executes processes. It caters to finance and banking, insurance, healthcare, telecom, manufacturing, BPOs, and shared service organizations. Daniel Dines and Marius Tirca founded UiPath in 2005, with its headquarters in New York City. It has additional offices in London in the United Kingdom, Paris in France, Bucharest in Romania, Tokyo in Japan, Singapore, Bengaluru in India, and Melbourne in Australia.

ImCheck Therapeutics

Series C in 2022
ImCheck Therapeutics SAS develops immunotherapeutics for patients with severe unmet medical needs. The company primarily focuses on immuno-oncology. It develops immunotherapy antibodies, which include immunomodulators and butyrophilins to treat a range of autoimmune diseases. The company was founded in 2015 and is based in Marseille, France.

Rakuten

Venture Round in 2005
Rakuten France operates a French online e-commerce website. It provides new, used, and collectable products at fixed prices for individuals and professionals in Europe. The company enables its customers to list items by entering the title or barcode of the item as well as the price at which the seller wishes to sell the product. It lists items under various categories, including books, music, DVD, VHS, video games, phones and PDAs, computing, electronics, sports, leisure, fashion, and toys and games. Rakuten France is formerly PriceMinister, a company acquired by Rakuten 2010. It was founded in August 2000 and is based in Paris, France.

import.io

Seed Round in 2013
Import.io is the number one Web Data Integration provider. Import.io deliver the world’s data directly to enterprises, fueling business insight and competitive advantage. The Import.io Web Data Integration solution extracts, prepares and integrates high-quality comprehensive web data into customers’ analytics platforms and business applications. The company delivers data to more than 850 customers from millions of web sources.

AYOXXA

Series A in 2012
AYOXXA is a biotech company commercializing innovative technology developed at the National University of Singapore (NUS). AYOXXA’s patented technology platform is producing a new generation of biochips – merging biology with IT. This allows the biochip to accumulate large numbers of applications – measuring multiple protein markers for cancer, allergies, cardiovascular and infectious diseases – in a single test.

ImCheck Therapeutics

Private Placement in 2019
ImCheck Therapeutics SAS develops immunotherapeutics for patients with severe unmet medical needs. The company primarily focuses on immuno-oncology. It develops immunotherapy antibodies, which include immunomodulators and butyrophilins to treat a range of autoimmune diseases. The company was founded in 2015 and is based in Marseille, France.

SuperSonic Imagine

Private Equity Round in 2013
SuperSonic Imagine SA operates as a medical technology company. It designs, develops, and markets Aixplorer, an ultrasound system. It has developed a technology that offers practitioners and patients a breakthrough in the diagnosis and follow up of breast, prostate, and thyroid cancers, as well as liver diseases. The company’s products include Aixplorer, an ultrasound system that renders images with exceptional definition, contrast, and resolution. It operates primarily in China, the United States, and France. The company was founded in 2005 and is headquartered in Aix-en-Provence, France. SuperSonic Imagine SA is a subsidiary of Hologic Hub Ltd.

Experteer

Series B in 2010
Experteer offers an online platform that enables its users to search, find, and apply for job opportunities in Germany and Europe. It also enables individuals to find insights and articles about headhunter industry. Experteer was founded by Christian Gottsch and Konstantin Urban and is based in Munich, Germany.

Heliatek

Series C in 2014
Heliatek GmbH develops and manufactures organic solar films and photovoltaics cells. Its product includes HeliaSol, an organic photovoltaics (OPV) solution that can be applied to surfaces. The companys’s product is used for building, automotive, and pilot projects applications. The company serves building and construction material companies, automotive manufacturers, and suppliers. Heliatek GmbH has strategic partnerships with AGC Glass Europe, and Reckli China. The company was founded in 2006 and is based in Dresden, Germany.

Sapiens Steering Brain Stimulation

Series A in 2011
Sapiens Steering Brain Stimulation GmbH is an emerging medical device company whose mission is to deliver superior solutions for deep brain stimulation (DBS) therapy. Sapiens' ambition is to provide a unique, high-resolution, and MRI- compatible DBS system that will improve patient comfort and therapeutic outcome, initially for patients with Parkinson's disease. Sapiens, with offices in Eindhoven, the Netherlands and Munich, Germany, is founded in 2011 as a spin-out of Royal Philips Electronics. Its steering brain stimulation (SBS) system and image-guided programming are based upon patented technologies.

Koa Health

Series A in 2021
Koa Health is digital wellbeing and therapeutics solutions combine the latest clinical research and breakthrough technologies. It delivers mental health support that is accessible, personalized, and effective across a range of conditions. They create digital tools and resources for mental health that encompass prevention, prediction, and treatment.

GLO

Venture Round in 2017
glo AB develops and commercializes direct-emitting red, green, and blue display panels for displays, illumination, and automotive sectors. The company offers microLEDs products through original equipment manufacturer and manufacturing partners. Its products have application in phone and watch displays, virtual and augmented reality, tiled huge walls displays, on-retina displays, and television. The company was founded in 2005 and is based in Lund, Sweden with an office in Sunnyvale, California.

Dalia Research

Seed Round in 2015
Dalia develops B2B/SaaS solutions to facilitate market and opinion research in >100 countries. They harness the app economy and advanced data science to distribute millions of micro-surveys worldwide to gather and analyse real-time data on consumer attitudes, public opinion, and market trends. Backed by some of Europe’s leading venture capital firms, Dalia is a dynamic and fast-paced tech startup with an exceptionally talented team from 19 different countries driven by one mission: to generate information that helps us better understand the world around us.

Orcan Energy

Private Equity Round in 2022
Orcan Energy is the leader in waste heat recovery technology. Orcan Energy GmbH was founded in 2008, as a spin-out from the Technical University of Munich (“TUM”). Orcan’s ePack offers a compact, service-reduced and cost- efficient “plug-and-play” waste heat power generator based on ORC-Technology. Spe- cific patented innovations enable Orcan to popularize the technology on the mass mar- ket. At the beginning of 2013, Orcan gained sponsorships from the Exist-Research- Transfer-Aid of the Federal Government of Germany and additional grants from the “Wissensfabrik” and various resources from the TUM.

Adviqo

Series D in 2007
ADVQ, founded in 2000 and headquartered in Berlin/Germany, is a diversified media group with multiple online and offline properties directed towards female audiences. It is the world market leader in live counseling services in the areas of life advice, therapeutic counseling and coaching advice. With over 350 employees and offices in 5 countries (Germany, UK, France, Spain, Poland) the company is operating TV channels, online marketplaces and eCommerce sites as well as mobile applications. The company is an exclusive advice content partner for leading women magazines such as Bild, Bild der Frau, IN Star&Style but also large online portals such as GMX, T-Online and Freenet. With a top management team with backgrounds from BigPoint, HomeAway.com, BWin.com, Axel Springer, T-Online and backed by renowned investors like Wellington Partners, AGF and the European Founders Fund – the company has enjoyed high double digit $M revenues and high profitability.

Collax

Series A in 2005
Collax GmbH develops and offers Linux-based server solutions for small to medium sized companies. It offers Collax Business Server, a Linux-based server solution, which enables to build and maintain network; Collax OX Server, which is used for internal and global interchange of information; Collax Security Gateway, a network security solution for unified threat management; and appliances. The company's solutions include network security, solutions platform, and integration framework. In addition, it offers solutions, such as data, database, e-mail, collaboration, fax, proxy, Web-server via router, virtual private network, firewall, virus and spam protection, and Web content filters. The company was founded in 2005 and is based in Ismaning, Germany with additional offices in Munich, Germany; and Boston.

SNIPR Biome

Private Placement in 2019
SNIPR Biome is a operator of a discovery stage biotech company intended to revolutionize the treatment of microbial diseases. The company uses CRISPR technology that can subvert elements of the endogenous bacterial CRISPR machinery to eliminate hazardous bacteria in vivo, providing the health professionals with medicines that selectively target and kill bacteria with specific DNA sequences.

Readmill

Series A in 2012
Readmill, a Berlin, Germany-based social and shareable reading platform. Led by CEO Henrik Berggren, Readmill allows users to highlight parts of an ebook, share these highlights with friends and start discussions around them. The company also announced partnerships with six major independent stores including Leanpub, Readlists, Free-ebooks.net, Jottify, OR Books, Publit, and Bibliocrunch.

GLO

Series E in 2016
glo AB develops and commercializes direct-emitting red, green, and blue display panels for displays, illumination, and automotive sectors. The company offers microLEDs products through original equipment manufacturer and manufacturing partners. Its products have application in phone and watch displays, virtual and augmented reality, tiled huge walls displays, on-retina displays, and television. The company was founded in 2005 and is based in Lund, Sweden with an office in Sunnyvale, California.

Enecsys

Series B in 2011
Enecsys Limited, develops, manufacturers, and markets world-leading, highly reliable, grid-connected solar micro inverters and monitoring systems that offer an outstanding value proposition for solar PV systems. The micro inverter accepts DC power from each solar module and converts it into clean AC power for supply to the electricity grid. The advantages of Enecsys solar micro inverters include: maximized energy harvest, improved safety, increased lifetime and reliability, enhanced performance monitoring, and simplified PV array design and installation. The monitoring system tracks, in real-time, the performance of each PV module and transmits the information through a robust built-in wireless communication system that connects to the Internet via a gateway. Headquartered in Cambridge, UK, the company also has sales and support offices in Bad Homburg, Germany; Redwood Shores, California, USA; and Taipei, Taiwan. For more information, please visit www.enecsys.com..

import.io

Series B in 2018
Import.io is the number one Web Data Integration provider. Import.io deliver the world’s data directly to enterprises, fueling business insight and competitive advantage. The Import.io Web Data Integration solution extracts, prepares and integrates high-quality comprehensive web data into customers’ analytics platforms and business applications. The company delivers data to more than 850 customers from millions of web sources.

Bookatable

Venture Round in 2009
With a network of more than 65,000 restaurants worldwide and more than 27 million monthly visits, TheFork, a TripAdvisor® company, is the largest online restaurant reservation platform in Europe, Australia, and Latin America. The network operates in France and Switzerland as "LaFourchette" and in Spain as "ElTenedor" and in Italy, the Netherlands, Belgium, Portugal, Brazil, Denmark, Australia, Argentina, Brasil, Chile, Colombia, Mexico, Peru, and Uruguay as "TheFork."

Evolva

Series B in 2009
Evolva was founded in 2004 around a distinctive, proprietary, technology platform that uses synthetic biology to create innovative small molecule drugs and other compounds. In particular their platform allows the creation of chemistries that recapitulate the themes found in natural products, but without the disadvantages of those approaches.

EyeEm

Seed Round in 2011
EyeEm Mobile GmbH operates as a photography community and platform company globally. It offers EyeEm, a place for photographers of various abilities to share, interact, and learn about taking pictures on various devices, as well as attracts brands and media that want to feature photos in magazines, digital media, and advertising. The company’s API gives developers access to various albums and photos. EyeEm Mobile GmbH was founded in 2011 and is based in Berlin, Germany with talent in San Francisco and New York.

Orcan Energy

Series A in 2011
Orcan Energy is the leader in waste heat recovery technology. Orcan Energy GmbH was founded in 2008, as a spin-out from the Technical University of Munich (“TUM”). Orcan’s ePack offers a compact, service-reduced and cost- efficient “plug-and-play” waste heat power generator based on ORC-Technology. Spe- cific patented innovations enable Orcan to popularize the technology on the mass mar- ket. At the beginning of 2013, Orcan gained sponsorships from the Exist-Research- Transfer-Aid of the Federal Government of Germany and additional grants from the “Wissensfabrik” and various resources from the TUM.

SIRS Therapeutics

Seed Round in 2020
SIRS Therapeutics operates as a therapeutics company.

Cavendish Kinetics

Series B in 2006
Cavendish Kinetics, Inc. designs, manufactures, and markets tunable components for RF circuits for cellular handsets, laptops, netbooks, tablets, and other consumer wireless devices. It offers antenna tuners for various RF applications. The company offers its products directly to customers worldwide. Cavendish Kinetics, Inc. was founded in 1994 and is headquartered in San Jose, California with an additional office in s-Hertogenbosch, the Netherlands. As of October 4, 2019, Cavendish Kinetics, Inc. operates as a subsidiary of Qorvo, Inc.

amiando

Seed Round in 2007
amiando is a pioneer in online event registration and ticketing. Since its foundation in 2006, amiando has become a leading software-as-a-service platform for professional events. amiando’s products help event organizers to reach a professional level of event organization which, until now, was only reserved for large corporations and event agencies. All tools are online-based and immediately available for use, without the need for software installation. Over 180,000 event organizers worldwide use amiando, including prestigious names such as Facebook, BMW, UNESCO, and Telefónica O2. amiando has been awarded numerous prizes for its innovative products, among them the “Technology Pioneer of 2010” at the World Economic Forum, and the “eco Internet Award” as the best business client portal. amiando has been part of XING AG since December 2010, an operator of the business network XING.

UroMems

Series A in 2016
UroMems SAS designs, develops, and commercializes implantable medical devices. It manufactures MyoElectroMechanical System, an implantable, electronic artificial urinary sphincter (eAUS) for patients who suffer from severe urinary incontinence which increases the urethral pressure when the patient is engaged in a physically demanding activity and decreases the pressure when the patient's activities do not require high compression on the tissues. The company was founded in 2011 and is based in Grenoble, France.

Tonsser

Private Placement in 2018
Social network and utility app for youth soccer players who use Tonsser every week to keep track of their stats, improve their player rating, be inspired on how to improve and engage with their community.

Adrenomed

Private Placement in 2020
Adrenomed AG, a biopharmaceutical company, engages in the development of monoclonal antibody therapies for the treatment of sepsis. The company develops Adrecizumab, a humanized monoclonal antibody drug candidate against Adrenomedullin, a vasoactive peptide hormone released by vascular endothelial cells. Adrenomed AG was founded in 2009 and is based in Hennigsdorf, Germany.

MTM Laboratories

Series C in 2006
mtm laboratories AG is an ISO 9001 and 13485 certified developer and manufacturer of In-Vitro Diagnostics for the early detection and diagnosis of cervical and other cancers. With headquarters in Heidelberg, Germany, and subsidiaries in the United States, France, Italy and Spain, mtm markets its proprietary CINtec(R) Histology Kit and CINtec(R) Cytology Kit as adjunct tools for the early detection and diagnosis of cervical cancer. These kits are based on mtm's proprietary E6H4(TM) antibody clone which was specifically developed for immunochemistry applications in both formalin-fixed paraffin-embedded tissue sections and alcohol fixed cervical cytology preparations. The target for mtm's cervical cancer early detection technology platforms is the evaluation of the over-expression of the cyclin-dependent kinase inhibitor p16INK4a. This sensitive and selective antibody clone is combined with GMP manufactured kit components to ensure reproducible quality and results.

Zopa

Venture Round in 2015
Zopa Limited owns and operates an online marketplace lending platform, which allows individuals in the United Kingdom to access unsecured loans, facilitated by funds provided by both individuals and institutions. The platform offers car loans, debt consolidation loans, home improvement loans, wedding loans, and peer-to-peer investments. Zopa Limited was incorporated in 2004 and is based in London, United Kingdom.

NEUWAY Pharma

Series A in 2015
NEUWAY Pharma GmbH had been founded in April 2014 as the first spin-off from Life Science Inkubator GmbH. NEUWAY is focusing on the preclinical and clinical development of innovative therapeutics for treatment of orphan brain diseases based on its proprietary CNS drug delivery platform. The company also intends to partner its drug delivery technology for other CNS indications.

Middle Peak Medical

Series A in 2013
Middle Peak Medical is a privately held medical device company focused on the development and commercialization of a novel technology to treat mitral valve disease. The company’s proprietary device has application in both percutaneous catheter-based intervention, and in minimally invasive or open-heart cardiac surgery.

Atopix Therapeutics

Series A in 2014
Atopix Therapeutics Limited is a privately held, clinical-stage, biopharmaceutical company based in Oxford, UK, with an innovative approach to allergy. The company is developing a novel class of oral anti-allergic medicines, called CRTH2 antagonists, to treat atopic dermatitis, asthma and allergic rhinitis. Its lead candidate is currently being studied in a Phase 2 clinical trial for moderate to severe atopic dermatitis in several leading European dermatology centres.

Ingent

Series A in 2007
Ingent Inc., a Germany-based provider of information retrieval infrastructure technologies for computer applications.

Dacuda

Venture Round in 2014
Dacuda is a computer vision company that redefines the capabilities of cameras with real-time 2D and 3D algorithms. As the leading pioneer in software 3D camera technology, Dacuda's mission is to bring 3D capturing to every consumer by making 3D content creation as easy as taking a video. Dacuda's software 3D camera helps scale existing 3D use cases to consumers with app-based scanning and enables novel experiences for Augmented and Virtual Reality headsets. Dacuda is headquartered in Zurich, Switzerland, with locations in Palo Alto, California and Shanghai, China.. Awards include: Venture Leaders Asia 2014, Gartner Cool Vendor 2013, Entrepreneur of the Year 2012 by Ernst & Young, HEC Prix Strategis 2012, Swiss Economic Award 2011, HSG Entrepreneur of the Year 2011, Swiss Innovation Prize by IDEE SUISSE, Venture Leaders 2010, Venture Kick, ETH Spin-Off Label, CTI Start-up Label

Tonsser

Seed Round in 2017
Social network and utility app for youth soccer players who use Tonsser every week to keep track of their stats, improve their player rating, be inspired on how to improve and engage with their community.

Dalia Research

Seed Round in 2015
Dalia develops B2B/SaaS solutions to facilitate market and opinion research in >100 countries. They harness the app economy and advanced data science to distribute millions of micro-surveys worldwide to gather and analyse real-time data on consumer attitudes, public opinion, and market trends. Backed by some of Europe’s leading venture capital firms, Dalia is a dynamic and fast-paced tech startup with an exceptionally talented team from 19 different countries driven by one mission: to generate information that helps us better understand the world around us.

GameDuell

Venture Round in 2008
GameDuell is a cross-platform games community, developing games for its website as well as for social networks and mobile devices. With more than 125 million registered players across all platforms, the Berlin-based company counts among the casual and social games providers in the Western markets. GameDuell offers a broad portfolio of over 70 casual online games, mostly developed in-house, such as Fluffy, Maya Pyramid, Bubble Speed, Jungle Jewels, and game classics like Hearts, Solitaire, and Pool. It has a team of 210 experienced members. GameDuell was founded in 2003 by Kai Bolik, Michael Kalkowski, and Boris Wasmuth GameDuell. It is based in San Francisco, C.A.

WLAN AG

Venture Round in 2002
WLAN AG is a wireless local area network distributor. It focuses on the professional client support with regard to evaluation, planning, implementation, operation, and support of WLAN and network access control solutions. It offers its users with network engineering, operations, troubleshooting, and WLAN engineering services. The company offers solutions for network access controlling, public transport systems, and public WLAN. WLAN AG is a Switzerland-based company that was founded in 2004. The company was acquired by Swisscom Eurospot on March 7, 2003.

Onfido

Series B in 2016
Onfido digitally proves a user’s real identity using AI technology, by verifying their photo ID and comparing it to their facial biometrics. It means users and businesses can verify their online identities anywhere and anytime, without compromising on experience, inclusion, privacy or security. Onfido powers over 1,500 fintech, banking, and marketplace clients globally—helping them onboard more users while reducing risk. Identity underpins all transactions, and over the coming years, access to everything will be based on every user's ability to easily and securely prove their legal identity. This will change how we think of access—everything from opening a bank account to self-checking-in to a hotel, and ultimately voting.

Astaro

Series A in 2003
[Astaro](http://www.astaro.com/) develops a complete line of network security products including the Astaro Security Gateway software and Astaro Security Gateway line of security appliances. All Astaro products offer nine security applications in three categories - Web Security, Email Security and Network Security - fully integrated on a single management platform. Astaro products are distributed by a worldwide network of 350 solutions partners who offer local support and services. via: [Astaro](http://www.astaro.com/)

UroMems

Private Placement in 2020
UroMems SAS designs, develops, and commercializes implantable medical devices. It manufactures MyoElectroMechanical System, an implantable, electronic artificial urinary sphincter (eAUS) for patients who suffer from severe urinary incontinence which increases the urethral pressure when the patient is engaged in a physically demanding activity and decreases the pressure when the patient's activities do not require high compression on the tissues. The company was founded in 2011 and is based in Grenoble, France.

VoiceObjects

Series B in 2004
VoiceObjects AG operates as a phone application server company. Its products include VoiceObjects Server, a phone application server that enables carrier-grade deployment and management of over-the-phone voice, video, text, and mobile Web self-service applications; and VoiceObjects Desktop, a GUI-based application for creating, testing, deploying, and monitoring self-service phone portals. The company also offers professional services, including consulting, training, and technical support services. Its customers include banking and financial services, communication, marketing agencies, industrial, travel and support, healthcare, government, entertainment and info-portals, and management service providers in the United States and internationally. The company has strategic partnerships with Alcatel, aperto move, Avaya, BEA, BusinessObjects, Cirquent GmbH, D+S solutions, EXCELSIS, Hermes SoftLab, Hewlett Packard, NextiraOne, Quinary, Sabio, Telenet GmbH, Unisys, and Voxeo. The company was formerly known as OneBridge AG and changed its name to VoiceObjects AG in July 2002. The company was founded in 2001 and is based in Bergisch Gladbach, Germany. As of December 9, 2008, VoiceObjects AG operates as a subsidiary of Voxeo Corporation.

Truphone

Series B in 2008
Truphone provides mobile network services. It has built state-of-the-art SIM software, intuitive management platforms. Truphone also enables other mobile operators to rapidly roll out support for eSIM enabled devices. With Truphone, enterprises and individuals are benefiting from our international SIM cards and worldwide subscriptions, providing global mobility.

Aloqa

Series A in 2009
Aloqa is a mobile service that proactively notifies users about interesting places, services, events, and people close to where they are. Once you download and start Aloqa, you need to just look at your phone and it shows you live information about interesting things in your vicinity like your favorite coffee shops, highly rated restaurants, local bargains and coupons, Facebook friends in the vicinity, even kid friendly events. When you change locations, Aloqa refreshes itself automatically and notifies you of the relevant set of services, points of interest, events, and friends close to your new location. Wherever you are, whenever you go. In addition, Aloqa provides an API for easy development of location-based services, especially for proactive and community oriented applications. Examples contain detecting automatically the proximity of two mobile targets (such as Facebook friends), sorting a buddy list by current distance and automatically updating the list as well as clique observation (show me when 3 out of 5 of my myspace girlfriends are nearby).

opvizor

Series A in 2014
Opvizor GmbH develops a cloud-based expert system, Opvizor which detects VMware configuration and operating issues within uploaded protocol files, configuration, event, and performance data. It discovers system integrity issues and helps to harden client’s system security; and provides administrators with security report, issues report, health check, and snapshot report. The company was founded in 2012 and is based in Vienna, Austria.

EyeEm

Series A in 2013
EyeEm Mobile GmbH operates as a photography community and platform company globally. It offers EyeEm, a place for photographers of various abilities to share, interact, and learn about taking pictures on various devices, as well as attracts brands and media that want to feature photos in magazines, digital media, and advertising. The company’s API gives developers access to various albums and photos. EyeEm Mobile GmbH was founded in 2011 and is based in Berlin, Germany with talent in San Francisco and New York.

CoMentis

Series C in 2007
CoMentis is a biotech company focused on the research and development of small molecule drugs to treat neurovascular diseases such as Alzheimer's disease (AD), age-related macular degeneration (AMD) and other cognitive disorders. Originally founded in 2004 as Athenagen, Inc., the company was re-named CoMentis following its August 2006 merger with Zapaq, Inc., which created a leading neurovascular disease franchise.

Mapillary

Series A in 2016
Mapillary AB operates an online street-level imagery platform that scales and automates mapping through collaboration, cameras, and computer vision. The company enables users to collect photos that are combined into a collective street level photo view through tools, such as smartphones and action cameras. It offers updated maps, automated mapping, mapillary driver, desktop uploader, and command line tools. The company was founded in 2013 and is based in Malmö, Sweden. As of June 18, 2020, Mapillary AB operates as a subsidiary of Facebook, Inc.

import.io

Series A in 2016
Import.io is the number one Web Data Integration provider. Import.io deliver the world’s data directly to enterprises, fueling business insight and competitive advantage. The Import.io Web Data Integration solution extracts, prepares and integrates high-quality comprehensive web data into customers’ analytics platforms and business applications. The company delivers data to more than 850 customers from millions of web sources.

Quanta

Series B in 2014
Quanta is a medical devices company that develops advanced haemodialysis systems for use in the home and clinic. Quanta is focused on the commercialisation and ongoing development of SC+, an innovative cartridge-based haemodialysis system. SC+ is a high performance, compact haemodialysis system providing clinical efficacy by utilising typical flow rates of traditional in-centre machines. SC+ supports the entire ‘Continuum of Care’ for dialysis patients, from nurse-assisted treatment through self-care in centre to home haemodialysis. Their system facilitates the seamless transition between treatment modalities providing the best tool to enable flexibility for patients, and treatment options for physicians.

NEUWAY Pharma

Series A in 2014
NEUWAY Pharma GmbH had been founded in April 2014 as the first spin-off from Life Science Inkubator GmbH. NEUWAY is focusing on the preclinical and clinical development of innovative therapeutics for treatment of orphan brain diseases based on its proprietary CNS drug delivery platform. The company also intends to partner its drug delivery technology for other CNS indications.

NexWave Solutions

Venture Round in 2005
NexWave Solutions, S.A. develops embedded and device software for the consumer electronics market. It offers NexGUI, a graphical user interface framework for set top boxes, personal video recorders, DTVs, cameras, and camcorders; NEXGUIBUILDER to design and generate applications that use NexGUI; and NEXBROWSER, a small-footprint HTML/XHTML/CSS/JavaScript browser. The company also provides Blu-ray stack that forms the core of the Blu-ray products; LibTRON to enable quick migration of µITRON applications and middleware to a Linux-based environment; and NSI (NexWave Software Infrastructure), a component-based software infrastructure for embedded software development. It has representations in Seoul, Korea; and Beijing, Shanghai, and Shenzhen in China. NexWave Solutions, S.A. was founded in 1998 and is headquartered in Montpellier, France with additional offices in Silicon Valley (Bay Area), California; and Tokyo, Japan.

EnOcean

Series C in 2005
EnOcean GmbH manufactures and markets energy harvesting technology systems, sensors, and radio frequency communication solutions for building and home automation, lighting, industrial, automated meter reading, and environmental applications. Its products include energy converters, energy harvesting wireless sensors, controllers, and software, starter kits, and development tools to help OEMs to implement energy harvesting wireless modules and products. It sells its products through distributors in Austria, Belgium, Brazil, Canada, China, Denmark, Finland, France, Germany, Ireland, Israel, Italy, Japan, the Netherlands, Norway, the Russian Federation, Slovenia, South Africa, Spain, Sweden, Switzerland, Turkey, the United States, the United Kingdom, and other Eastern European countries. The company was founded in 2001 and is based in Oberhaching, Germany.

GoodlifeMe AB

Private Placement in 2020
GoodlifeMe AB develops and operates software solution for healthcare industry. The company offers Sidekick, a social health game designed to engage users through entertaining health improvement and team building. It enables users to boost diet, get active, de-stress, keep track of vitals, join with others, and others; and helps diabetes prevention programs. The company was founded in 2013 and is based in Gothenburg, Sweden.

4SC

Post in 2015
4SC discovers and develops targeted, small-molecule drugs for the treatment of cancer and autoimmune diseases in indications with high unmet medical needs. These drugs are intended to provide innovative treatment options that are more tolerable and efficacious, and provide a better quality of life.

Mapillary

Seed Round in 2015
Mapillary AB operates an online street-level imagery platform that scales and automates mapping through collaboration, cameras, and computer vision. The company enables users to collect photos that are combined into a collective street level photo view through tools, such as smartphones and action cameras. It offers updated maps, automated mapping, mapillary driver, desktop uploader, and command line tools. The company was founded in 2013 and is based in Malmö, Sweden. As of June 18, 2020, Mapillary AB operates as a subsidiary of Facebook, Inc.

Stipe Therapeutics

Private Placement in 2019
STipe Therapeutics focuses on harnessing the innate immune system to battle cancer. The company has developed first-in-class drugs targeting intracellular protein-protein interactions of the STING Pathway; a major driver of innate immunity, and regulator of tumorigenesis and autoimmune disorders. The company has identified and validated compounds that sensitizes the STING pathway and by this modulates the tumor microenvironment to support a potent anti-tumoral response.

Artfinder

Series B in 2012
Artfinder is the art marketplace creating a world where art benefits everyone. Artfinnder connects art lovers with independent artists around the world. When you buy art from Artfinder you support independent artists in over 100 countries, helping them to make a living from art. Artfinder is the first Certified B Corporation in the art world, balancing social purpose and environmental responsibility with purpose and profit. • 600,000+ subscribers around the world • 10,000+ artists and galleries internationally • 500,000+ artworks in categories including painting, printmaking, photography, sculpture, drawing and collage

Truphone

Series A in 2007
Truphone provides mobile network services. It has built state-of-the-art SIM software, intuitive management platforms. Truphone also enables other mobile operators to rapidly roll out support for eSIM enabled devices. With Truphone, enterprises and individuals are benefiting from our international SIM cards and worldwide subscriptions, providing global mobility.

ImevaX

Series A in 2014
ImevaX GmbH develops specific vaccines against pathogens, which cause chronic infectious diseases. The company creates specific vaccines against immune evasion factors to control chronic and nosocomial infections. It offers vaccine against helicobacter pylori, which colonizes the stomach and is the cause of ulcer disease and gastric cancer in humans. The company was founded in 2014 and is based in Munich, Germany.

Jellynote

Seed Round in 2014
Jellynote is the go-to-destination for over 1 million aspiring musicians; a loyal community who enjoy sheets, tabs and chords, original video content and the opportunity to connect with one-another in the Jellynote universe. Jellynote has developed all of its proprietary technology in-house, delivering an intuitive AI-powered edtech platform to its fans. Jellynote sells premium subscriptions and generates revenue from ads. Jellynote offers over 400,000 songs that you can be played to learn through original artist video master classes, video tutorials, sheets, tabs, chords and instrument view for a wide range of instruments. The game mode provides instant feedback and social mode connects musicians share their tastes in music. The Jellynote universe demonstrates how music can connect people in a world that is getting more and more divided. Available on Smartphone and desktop.

Industrial Origami

Series B in 2006
Industrial Origami offers patented metal folding designs and technologies through licenses, sub-licenses, and direct supply manufacturing aspects. The company’s technology allows thinner sheet material to be folded into complex and high load-bearing structures. It also enables its customers to incorporate its patented technology into their existing or new products by providing technology licenses and sub-licenses, as well as professional design services. Industrial Origami uses a patented technology that simplifies the design and assembly of products resulting in reduced product costs, innovative designs, and precision manufacture not possible using traditional forming methods. It also offers contract manufacturing through its partner network.

Replisaurus

Series A in 2006
Replisaurus Technologies develops metallization solutions for the electronics industry. It offers ElectroChemical Pattern Replication (ECPR), a metallization technology process for semiconductor manufacturing markets; production solutions, including master electrodes, integrated ECPR tools, chemicals, and processing guidelines; and die-to-die, die-to-wafer bonding, and nano imprint lithography solutions. The company’s products have applications in IC metallization, pad redistribution, and power metal/power distribution; integrated passive devices substrates, including coils, capacitors, and resistors; flip chip substrates, interposers, chip carriers, and SIP substrates; micro bumps; and nano electronics and micro systems metallization, opto substrates, and chip coils. Replisaurus Technologies AB offers its solutions to the manufacturers of packaging, substrates, optical components, and semiconductor devices.

EnOcean

Series A in 2002
EnOcean GmbH manufactures and markets energy harvesting technology systems, sensors, and radio frequency communication solutions for building and home automation, lighting, industrial, automated meter reading, and environmental applications. Its products include energy converters, energy harvesting wireless sensors, controllers, and software, starter kits, and development tools to help OEMs to implement energy harvesting wireless modules and products. It sells its products through distributors in Austria, Belgium, Brazil, Canada, China, Denmark, Finland, France, Germany, Ireland, Israel, Italy, Japan, the Netherlands, Norway, the Russian Federation, Slovenia, South Africa, Spain, Sweden, Switzerland, Turkey, the United States, the United Kingdom, and other Eastern European countries. The company was founded in 2001 and is based in Oberhaching, Germany.

Enecsys

Series A in 2009
Enecsys Limited, develops, manufacturers, and markets world-leading, highly reliable, grid-connected solar micro inverters and monitoring systems that offer an outstanding value proposition for solar PV systems. The micro inverter accepts DC power from each solar module and converts it into clean AC power for supply to the electricity grid. The advantages of Enecsys solar micro inverters include: maximized energy harvest, improved safety, increased lifetime and reliability, enhanced performance monitoring, and simplified PV array design and installation. The monitoring system tracks, in real-time, the performance of each PV module and transmits the information through a robust built-in wireless communication system that connects to the Internet via a gateway. Headquartered in Cambridge, UK, the company also has sales and support offices in Bad Homburg, Germany; Redwood Shores, California, USA; and Taipei, Taiwan. For more information, please visit www.enecsys.com..

AMBOSS

Series B in 2019
AMBOSS is a medical technology company with offices in New York, Berlin and Cologne. Its knowledge platform has fundamentally changed the way medical know-how is acquired and utilized at the point-of-care. Students use the interactive library and high-yield question bank for general study and exam preparation, while doctors rely on AMBOSS to make effective clinical decisions guided by evidence-based recommendations. Founded in 2012 by doctors for doctors, the company’s international team has grown to over 200 physicians, scientists and software engineers, all striving to better serve doctors around the world. Today, more than half a million healthcare professionals in over 180 countries rely on AMBOSS.

Tonsser

Series A in 2018
Social network and utility app for youth soccer players who use Tonsser every week to keep track of their stats, improve their player rating, be inspired on how to improve and engage with their community.

eGenesis

Series C in 2021
Egenesis Inc., a biotechnology company, operates as a gene editing and genome engineering that develops human transplantable organs, tissues, and cells. It offers a gene editing platform for developing human compatible organs. The company also provides development, such as gene engineering, single cell cloning, somatic cell nuclear/embryo transfer, organ procurement, and transplantation. The company was incorporated in 2015 and is based in Cambridge, Massachusetts with an additional office in New York, New York.

Garderos Software Innovations

Series B in 2004
Garderos makes industrial-grade routers which are self-managing and cyber-secure. They work with their customers to make sure that their multi-site router projects are fully-functional and secure against cyber-attacks.

Codeonline

Series A in 2001
Codeonline Ltd., a developer of interactive mobile entertainment, and Springtoys, a developer of wireless gaming technology, have agreed to merge to create what they claim will be the world’s largest wireless entertainment company. Under the terms of the agreement, the merger will be carried out through a share swap.

Onward

Series A in 2016
GTX Medical is developing an Implantable Neuro-stimulation System (INS) with real-time motion feedback and uses training tools to rehabilitate patients suffering from neurological disorders such as spinal cord injury (SCI).

Implanet

Series A in 2007
Implanet S.A., together with its subsidiaries, designs, manufactures, and sells implants for orthopedic surgery in France, the United States, Brazil, and internationally. The company offers spinal, arthroscopy, and knee products. Its products include Jazz, Jazz Passer, Jazz Cap SP, Jazz Lock, Jazz Claw, Jazz Standalone, Jazz Frame, and Jazz Screw systems for posterior fixation. The company also offers knee prostheses, such as Madison for conventional surgical techniques. Implanet S.A. was founded in 2006 and is based in Martillac, France.

Rigontec

Series A in 2015
Rigontec GmbH is a biopharmaceutical company that develops RNA-based immunotherapeutics for the treatment of cancer and viral diseases. The company develops ImOl100, a compound stimulating the immune receptor retinoic acid-inducible gene I, which recognizes viral RNA. Its ImOl100 is also a minimal mimic of naturally occurring 3pRNA, a motif typically occurring in viral RNAs. The company’s compounds avoid the pitfalls of cancer vaccines, checkpoint inhibitors, and therapeutics based on the identification of tumor antigens. Rigontec GmbH was founded in 2014 and is based in Planegg, Germany. As of October 26, 2017, Rigontec GmbH operates as a subsidiary of Merck & Co., Inc.

YPlan

Seed Round in 2012
YPlan uncovers the best events every day so you can get out and Live Your City. Get the lowdown on cool dates, hidden culture and where to hang with friends. Discover, book, go – it's that simple. Flash your YPlan ticket and you're in. Founded in London in February, 2012, YPlan works directly with 3500+ event partners worldwide, has over 1.5 million users, and 1000+ 5* reviews on App Store.

Hailo

Series A in 2012
FREE NOW (formerly mytaxi) is a leading mobility provider. FREE NOW currently operates in London, Brighton, Edinburgh, Manchester, Nottingham, Oxford, Reading, Derby and Leicester. With two requests every second, FREE NOW directly connects passengers and drivers with just two taps of the app. FREE NOW is part of the mobility joint venture between BMW and Daimler, formed in February 2019. In July 2016, mytaxi announced the merger with Hailo, the leading taxi app in the UK and Ireland - an important step towards becoming Europe's largest e-hailing app.

eCircle

Venture Round in 2000
eCircle provides software and services for email marketing in Europe. It offers software for email and SMS broadcasting, and email address data for newsletter mailings and email/SMS/MMS campaigns, as well as consulting services and social media functionalities. The company was founded in 1999 and is based in Munich, Germany with additional offices in the United Kingdom, France, Spain, the Netherlands, and Italy.

Ember

Debt Financing in 2010
Ember is a design-led temperature control brand whose mission is to revolutionize the way people eat, drink and live. Founded by inventor and serial entrepreneur Clay Alexander, Ember designs and develops patented technology and products that disrupt industries across healthcare, wellness, consumer products and more. From inventing the world’s first temperature control smart mug, to revolutionizing the cold chain for temperature sensitive medicines, Ember is creating a multidisciplinary temperature control platform that brings precision temperature control to your fingertips.

Themis Bioscience

Series B in 2016
Themis Bioscience is a start-up biotechnology company developing vaccines to prevent infectious diseases. The company’s development focus is primarily concentrated on emerging and specialist indications, advancing promising vaccines from preclinical to late-stage clinical development phases. We aim to exploit the increasing licensing and acquisition trend to generate value by developing and partnering our technology programs and vaccine candidates. It is our mission to establish Themis as a first class biotech development boutique and to become a preferred licensing partner for leading biotech and pharmaceutical companies.

Artfinder

Venture Round in 2016
Artfinder is the art marketplace creating a world where art benefits everyone. Artfinnder connects art lovers with independent artists around the world. When you buy art from Artfinder you support independent artists in over 100 countries, helping them to make a living from art. Artfinder is the first Certified B Corporation in the art world, balancing social purpose and environmental responsibility with purpose and profit. • 600,000+ subscribers around the world • 10,000+ artists and galleries internationally • 500,000+ artworks in categories including painting, printmaking, photography, sculpture, drawing and collage

IconOVir Bio, Inc.

Private Placement in 2020
IconOVir Bio, Inc. engages in the research and development of biopharmaceutical products. IconOVir Bio, Inc. was formerly known as TRC 1802, Inc. and changed its name to IconOVir Bio, Inc. in June 2020. The company was incorporated in 2018 and is based in New York, New York.

UroMems

Series B in 2020
UroMems SAS designs, develops, and commercializes implantable medical devices. It manufactures MyoElectroMechanical System, an implantable, electronic artificial urinary sphincter (eAUS) for patients who suffer from severe urinary incontinence which increases the urethral pressure when the patient is engaged in a physically demanding activity and decreases the pressure when the patient's activities do not require high compression on the tissues. The company was founded in 2011 and is based in Grenoble, France.

Ztory

Seed Round in 2014
Ztory is a Swedish startup that gives readers access to an ever growing stockpile of magazines, children’s books and other illustrated publications for a fixed price each month. Our mission is to develop peoples interests by connecting them to the best publications on subjects they love.

Edge Intelligence Software

Private Placement in 2018
Edge Intelligence Software, Inc. develops a relational database management system (RDBMS), which enables a single database to load large volumes of data in real time, whilst extracting information without the need for an interim index or data warehouse. The company’s product includes EdgeIntelligence which is an enterprise software solution that consists of three integrated components, including EdgiStore which is a data store that keeps everything and enables the query of anything; EdgiStar which provides the orchestration and access to a network of EdgiStores; and EdgiSafe that offers a seam of security that runs through everything to ensure the safety of all of the data stored at the edge of the network and the safety of any data moved across the network. Further, the company offers centralized management and access to terabytes of data which is collected and analyzed close to its source. The company was founded in 2010 and is based in San Francisco, California with an office location in Bristol, United Kingdom.

Carisma Therapeutics

Series B in 2021
CARISMA Therapeutics Inc., a biotechnology company, develops CAR macrophages, an approach to immunotherapy. CARISMA Therapeutics Inc. was formerly known as CARMA Therapeutics Inc. and changed its name to CARISMA Therapeutics Inc. in June 2018. The company was incorporated in 2016 and is headquartered in Philadelphia, Pennsylvania.

webme

Series A in 2008
Webme is a web-hosting site that is based in Germany.

Open Mobile Corp.

Venture Round in 2000
A new US-registered company with its roots in Scandinavia.

Hailo

Venture Round in 2013
FREE NOW (formerly mytaxi) is a leading mobility provider. FREE NOW currently operates in London, Brighton, Edinburgh, Manchester, Nottingham, Oxford, Reading, Derby and Leicester. With two requests every second, FREE NOW directly connects passengers and drivers with just two taps of the app. FREE NOW is part of the mobility joint venture between BMW and Daimler, formed in February 2019. In July 2016, mytaxi announced the merger with Hailo, the leading taxi app in the UK and Ireland - an important step towards becoming Europe's largest e-hailing app.

Zopa

Series C in 2007
Zopa Limited owns and operates an online marketplace lending platform, which allows individuals in the United Kingdom to access unsecured loans, facilitated by funds provided by both individuals and institutions. The platform offers car loans, debt consolidation loans, home improvement loans, wedding loans, and peer-to-peer investments. Zopa Limited was incorporated in 2004 and is based in London, United Kingdom.

Rigontec

Series A in 2014
Rigontec GmbH is a biopharmaceutical company that develops RNA-based immunotherapeutics for the treatment of cancer and viral diseases. The company develops ImOl100, a compound stimulating the immune receptor retinoic acid-inducible gene I, which recognizes viral RNA. Its ImOl100 is also a minimal mimic of naturally occurring 3pRNA, a motif typically occurring in viral RNAs. The company’s compounds avoid the pitfalls of cancer vaccines, checkpoint inhibitors, and therapeutics based on the identification of tumor antigens. Rigontec GmbH was founded in 2014 and is based in Planegg, Germany. As of October 26, 2017, Rigontec GmbH operates as a subsidiary of Merck & Co., Inc.